United States · Investor

Catalio Capital Management

Last cheque observed Oct 2026; 108 cheques on record.

Deploying nowNew fund $20M, Sept 2026VC firm

SeedSeries ASeries BHealthcareDrugsAi-enabled

Deploying now
93%of best year42cheques in 12 months, 108 on record
Since the last cheque8days00hrs00min00sec
Median round$73MCheque size, as they say$100K – $5.0MRounds led4 of 108Sole investor10 roundsMostly inUnited States, 88%
Pitch Catalio Capital Management

Catalio Capital Management highlights

  1. 01

    42 cheques in the last 12 months

  2. 02

    Mostly Venture and Series B: 59% of its rounds

  3. 03

    Sole investor in 10 rounds, median $20M

What they do

A New York based investment firm focused on the full lifecycle of innovative healthcare investing, across private, public and credit markets.From their own website
Type
VC firm (from a list, unverified)
Cheque size
$100K – $5.0M as they say
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
HealthcareDrugsAi-enabled
Based in
New York, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first108 appearances

  1. 2026

    35 rounds

  2. Oct
    Star TherapeuticsUS · Pulse 2.0$200MWith 10 others
  3. Oct
    ZAP Surgical SystemsGrowth · US · AI Insider$36MLed
  4. Sept
    BigHat BiosciencesSeries C · US · Kevin Moore$75MWith 4 others
  5. Sept
    Basecamp ResearchSeries C · GB · Ventureburn$140MWith 17 others
  6. Sept
    Stuut TechnologiesSeries B · US · Ventureburn$53MLed
  7. Sept
    EvvySeries B · US · TechCrunch$40MLed
  8. Sept
    EnvedaSeries E · US$311MWith 3 others
  9. Sept
    IAMBICDebt · US$66MWith 5 others
  10. Sept
    AvavaVenture · US$30MSole investor
  11. Sept
    OpenEvidenceSeries E · US$250MWith 4 others
  12. Aug
    GeorgiamuneSeries B · US$93MWith 3 others
  13. Jul
    AdvanCellSeries D · AU · QRM Capital$315MWith 16 others
  14. Jul
    Claris BiotherapeuticsSeries B · US$118MWith 4 others
  15. Jul
    Cambrian BiopharmaVenture · US$124MWith 4 others
  16. Jul
    Leo Cancer CareSeries D · GB$65MWith 2 others
  17. Jul
    Ratio TherapeuticsSeries C · US$70MWith 1 other
  18. Jun
    FlourishGrowth · US · Ventureburn$500MWith 3 others
  19. Jun
    Parabilis MedicinesUS$75MWith 4 others
  20. May
    TheaPre-seed · US$4.0MWith 3 others
  21. May
    9amHealthSeries B · US$26MWith 3 others
  22. May
    Cartography BiosciencesVenture · USUndisclosedWith 4 others
  23. May
    ArriVentUS$250MWith 4 others
  24. May
    Odyssey TherapeuticsUS$25MWith 4 others
  25. Apr
    Spiral TherapeuticsSeries B · US · LifeLink Ventures$27MWith 1 other
  26. Apr
    Beacon BiosignalsSeries B · US$11MWith 3 others
  27. Mar
  28. Mar
    HyperfineDebt · US$40MWith 1 other
  29. Mar
    AvavaSeries D · US$20MSole investor
  30. Mar
    Dianthus TherapeuticsUS$719MWith 3 others
  31. Feb
    SomethingsSeries A · US · AlleyWatch$19MLed
  32. Feb
    COMPASS PathwaysGB$200MWith 4 others
  33. Feb
    ProSomnus Sleep TechnologiesVenture · US$38MSole investor
  34. Jan
    Parabilis MedicinesSeries F · US$305MWith 4 others
  35. Jan
    PrognomiQVenture · US$12MWith 4 others
  36. Jan
    Lila SciencesGrant · US$671KWith 3 others
  37. 2025

    35 rounds

  38. Dec
    Sidera BioSeries A · DK$109MWith 3 others
  39. Dec
    Protara TherapeuticsUS$75MWith 2 others
  40. Dec
    Medra AISeries A · US$52MWith 5 others
  41. Nov
    Beacon BiosignalsSeries B · US$86MWith 8 others
  42. Nov
    FreenomeVenture · US$75MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration5 named

GPGeorge PetrocheilosExecutive OfficeriFiling they signed
GPGeorgios PetrocheilosManager and Member of the ManageriFiling they signed
OEOlga Eduardovna MaltsevaChief Compliance Officer and Head of OperationsiForm ADV
RJR. Jacob VogelsteinManager and Member of the ManageriFiling they signed
RJRachel Jacob VogelsteinManager and Member of ManageriFiling they signed

We also hold 79 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$2.2Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
Legal name
Catalio Capital Management, LP
SEC number
CRD 310374

Funds on its Form ADV

15 private funds, $1.0B in gross assets · filed Mar 2024

Venture 9Private equity 3Hedge 1

  1. Catalio Nexus Fund III, L.P.Private equity327 investors$365M
  2. Catalio Nexus Fund IV, L.P.Private equity166 investors$191M
  3. Catalio Public Equities Master Fund, L.P.Hedge59 investors$109M
  4. Catalio Nexus Fund II, L.P.Private equity151 investors$88M
  5. Catalio Structured Opportunities Fund I L.P.Private credit83 investors$55M
  6. Catalio Genesis Fund I, LLCVenture54 investors$47M
  7. Catalio Genesis Fund II, LLCVenture100 investors$43M
  8. Catalio Genesis Fund III, LLCVenture77 investors$36M
  9. Catalio Structured Opportunities AIV I L.P.Structured credit80 investors$31M
  10. Catalio Access Fund V, LLCVenture60 investors$15M

And 5 more on the filing.

Who they invest alongside

The investors most often in the same rounds as Catalio Capital Management. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Catalio Capital Management put money into.

Quick answers about Catalio Capital Management

What does Catalio Capital Management invest in?

Catalio Capital Management invests most often at Venture and Series B (59% of the rounds on record), in sectors such as Healthcare, Drugs and Ai-enabled.

How active is Catalio Capital Management?

108 investments on record, 42 of them in the last 12 months, and it led 4. The most recent was in Oct 2026.

What has Catalio Capital Management invested in recently?

Its most recent investments on record: Star Therapeutics (Undisclosed round, Oct 2026), ZAP Surgical Systems (Growth, Oct 2026) and BigHat Biosciences (Series C, Sept 2026).

How big are Catalio Capital Management's cheques?

The median round it joins is $73M. It says it writes cheques of $100K to $5.0M.

Does Catalio Capital Management lead rounds?

Sometimes: it led 4 of its 108 investments on record (4%).

Where does Catalio Capital Management invest?

Most of the companies it backs are in the United States (88%) and the United Kingdom (8%).

Is Catalio Capital Management investing now?

Yes: it is actively investing, with 42 investments in the last 12 months.

Who does Catalio Capital Management invest alongside?

Most often General Catalyst (17 rounds together), RA Capital Management (17 rounds together) and Alumni Ventures (10 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it